Form 4: Elanco Animal Health Executive Vice President David S. Kinard Reports Changes in Beneficial Ownership
SEC Form 4
David S. Kinard, Executive Vice President of Elanco Animal Health, reports a transaction involving common stock on March 1, 2025.
Summary
- On March 1, 2025, David S. Kinard, an Executive Vice President at Elanco Animal Health Inc, reported a change in beneficial ownership of the company's common stock.
- The transaction involved the disposal of 7,162 shares at a price of $11.17.
- Following the transaction, Kinard directly owns 166,773 shares of Elanco Animal Health Inc.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of compliance for corporate insiders and provide transparency into their transactions in company stock. It is difficult to assess the impact of a single transaction without broader context.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Date of transaction involving Elanco Animal Health Inc common stock. |
| 03/04/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.